NAPA, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NAPA MEDICAL RESEARCH FOUNDATION, founded in 2014, is a small nonprofit that reported $327K in total revenue in fiscal year 2022. Revenue fell 52% from the prior year — a significant decline worth monitoring. Expenses of $970K exceeded revenue, resulting in a 197% operating deficit.
THE PURPOSE OF NAPA MEDICAL RESEARCH FOUNDATION IS TO ENGAGE IN CHARITABLE AND EDUCATIONAL ACTIVITIES AND TO CONDUCT CLINICAL AND BASIC SCIENCE RESEARCH RELATING TO THE DIAGNOSIS, TREATMENT AND CURE OF CONDITIONS AFFECTING NERVES, MUSCLES, BONES AND JOINTS IN ADULTS AND CHILDREN. IN ADDITION, OUR GOAL IS TO SHARE OUR FINDINGS WITHIN THEMEDICAL PROFESSION AND TARGET POPULATIONS TO BENEFIT THE PUBLIC GOOD. UNLIKE OTHER SMALL FOUNDATIONS THAT LIMIT THEIR FOCUS TO A LOCAL COMMUNITY, WE AIM TO SERVE HUMANITY AS A WHOLE.
THE PURPOSE OF NAPA MEDICAL RESEARCH FOUNDATION IS TO ENGAGE IN CHARITABLE AND EDUCATIONAL ACTIVITIES AND TO CONDUCT CLINICAL AND BASIC SCIENCE RESEARCH RELATING TO THE DIAGNOSIS, TREATMENT AND CURE...
THE PURPOSE OF NAPA MEDICAL RESEARCH FOUNDATION IS TO ENGAGE IN CHARITABLE AND EDUCATIONAL ACTIVITIES AND TO CONDUCT CLINICAL AND BASIC SCIENCE RESEARCH RELATING TO THE DIAGNOSIS, TREATMENT AND CURE OF CONDITIONS AFFECTING NERVES, MUSCLES, BONES AND JOINTS IN ADULTS AND CHILDREN.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $326,527 | $680,537 | -0.5% |
| Expenses | $970,097 | $549,023 | +0.8% |
| Net Income | $-643,570 | $131,514 | -5.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAMES VARTAN | EXECUTIVE DIRECTOR | 40.00 |
Highest
|
$466,654 | $0 | $466,654 |
| YVETTE URIBE | CLINICAL RESEARCHER | 40.00 |
Highest
|
$178,334 | $0 | $178,334 |
| MARKO BODOR MD | DIRECTOR OF MEDICAL RESEAR | 10.00 |
Officer
|
$37,500 | $0 | $37,500 |
| HANNA STOLARCZYK | SECRETARY | 5.00 |
Officer
Director
|
$7,000 | $0 | $7,000 |
| JOY ORDSTADT | TREASURER | 5.00 |
Officer
Director
|
$7,000 | $0 | $7,000 |
| ROBERT FOWLES | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| DANIEL MIRDA MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| KRISTI EBONG | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JEFFREY SHEN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| BETH NOVAK MILLIKEN | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ALEXANDER DE MORAES MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JUDITH A MYERS | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JOHN DIANA MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| ELIZABETH GRETCHEN DE BAUBIGNY | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| PHILIP WEINSTEIN MD | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| JOANN SERAFINI ROSS | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MICHAEL F T JACKSON | CHAIRMAN | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2022 | $326,527 | $970,097 | No data | $-643,570 |
| 2021 | $680,537 | $549,023 | $643,570 | $131,514 |
| 2020 | $640,543 | $567,556 | $517,056 | $72,987 |
| 2019 | $590,704 | $514,504 | $439,069 | $76,200 |
| 2018 | $520,383 | $477,333 | $362,659 | $43,050 |
Compare NAPA MEDICAL RESEARCH FOUNDATION with other nonprofits in California and across the country.